COPD薬剤の安全性情報：ATS

COPD患者への吸入抗コリン剤は心血管死、心筋梗塞、卒中リスク増加 [2008-09-24]以降もまだ当方には製薬会社からの情報が伝達されてない。

ACCPから「COPD治療に関する薬剤の安全性について重要な情報がリリースされた。この情報は医師・患者ともに関心をひき、重要なものであろう」・・・ということで提示されている。

Important Information About the Safety of COPD Drugs
http://www.chestnet.org/networks/airway_disorders/copd.php

Recently, there has been important information released about the safety of drugs used to treat COPD. This information could be of concern and have implications for physicians and their patients. Below are links to some of the articles and studies related to this topic:

* AP Wire article 9-23-08
"Inhaler Lung Drugs Tied to Heart Problems, Deaths"

* JAMA Study Abstract JAMA 2008; 300:1439-1450


* Boehringer Ingelheim Pharmaceuticals, Inc. Press Release 9-23-08
"Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial, UPLIFT; New Data From Landmark UPLIFT Trial Further Supports Spiriva’s Safety Profile"

* UPLIFT (Understanding Potential Long-term impacts on Function with Tiotropium) Safety Study Webcast Summary, Boehringer Ingelheim Pharmaceuticals, Inc.